Improver

Yuval Sagiv

VP R&D at NanoCarry Therapeutics

Israel

14 years of experience in drug development from early stages through animal models and toxicology studies. Management of process development, analytical and research teams in accordance with GMP regulations, participation in FDA and EMA inspections. Supervision of projects with subcontractors, collaborators and research laboratories in Israel and abroad.

A vast experience in the fields of autoimmune diseases, infectious diseases, as well as experience in Cancer therapy, dermatology and ophthalmology.
MSc and PhD in biochemistry and cell biology in the fields of protein transport and apoptosis, and a post doctorate in immunology focusing on lipid presentation to the immune system.

---

Experience:

• Head of Research (Target-In Ltd.)
• Head of Preclinical development (HealOr Ltd.)
• Director R&D, New products and preclinical development (Kamada Ltd.)
• Group manager (Kamada Ltd.)
• Director R&D, Processes and preclinical development (Kamada Ltd.)
• VP R&D (Nanocarry Therapeutics)
• post-doc (University of Chicago)

Skills: